Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease

Chest

Volumn 143, Issue 3, 2013, Pages 605-612

  Kahrilas, Peter J ^a   Howden, Colin W ^a   Hughes, Nesta ^b   Molloy Bland, Michael ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b OXFORD PHARMAGENESIS LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; RABEPRAZOLE; RANITIDINE;

ACID SUPPRESSIVE THERAPY; ANTIREFLUX THERAPY; CHRONIC COUGH; DRUG RESPONSE; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HUMAN; PATIENT SELECTION; PH MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; THERAPY;

EID: 84874988848     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1788     Document Type: Article

References (45)

1. Chang AB, Lasserson TJ, Kiljander TO, Connor FL, Gaffney JT, Garske LA. Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux. BMJ. 2006; 332 (7532): 11-17.
2. French CL, Irwin RS, Curley FJ, Krikorian CJ. Impact of chronic cough on quality of life. Arch Intern Med. 1998; 158 (15): 1657-1661.
3. Irwin RS, Richter JE. Gastroesophageal reflux and chronic cough. Am J Gastroenterol. 2000; 95 (suppl 8): S9 - S14.
4. Ing AJ, Ngu MC, Breslin AB. Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Respir Crit Care Med. 1994; 149 (1): 160-167.
5. Javorkova N, Varechova S, Pecova R, et al. Acidification of the oesophagus acutely increases the cough sensitivity in patients with gastro-oesophageal reflux and chronic cough. Neurogastroenterol Motil. 2008; 20 (2): 119-124.
6. Smith JA, Decalmer S, Kelsall A, et al. Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology. 2010; 139 (3): 754-762.
7. Bredenoord AJ. Mechanisms of reflux perception in gastroesophageal reflux disease: a review. Am J Gastroenterol. 2012; 107 (1): 8-15.
8. Morice AH, Fontana GA, Sovijarvi AR, et al ERS Task Force. The diagnosis and management of chronic cough. Eur Respir J. 2004; 24 (3): 481-492.
9. Chang AB, Lasserson TJ, Gaffney J, Connor FL, Garske LA. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev. 2006; (4): CD004823.
10. Kahrilas P, Hughes N, Howden C. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. Gut. 2011; 60 (11): 1473-1478.
11. Kahrilas PJ, Howden CW, Hughes N. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am J Gastroenterol. 2011; 106 (8): 1419-1425.
12. Teichtahl H, Kronborg IJ, Yeomans ND, Robinson P. Adult asthma and gastro-oesophageal reflux: the effects of omepra zole therapy on asthma. Aust N Z J Med. 1996; 26 (5): 671- 676.
13. Wo JM, Koopman J, Harrell SP, Parker K, Winstead W, Lentsch E. Double-blind, placebo-controlled trial with singledose pantoprazole for laryngopharyngeal reflux. A m J Gastroenterol. 2006 ;101(9):1972-1978.
14. Steward DL, Wilson KM, Kelly DH, et al. Proton pump inhibi tor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg. 2004; 131 (4): 342-350.
15. Havas T, Huang S, Levy M, et al. Posterior pharyngolaryngitis: double-blind randomised placebo-controlled trial of proton pump inhibitor therapy. Aust J Otolaryngol. 1999; 3(3): 243- 246.
16. Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope. 2006; 116 (2): 254-260.
17. Jaspersen D, Kulig M, Labenz J, et al. Prevalence of extraoesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther. 2003; 17 (12): 1515-1520.
18. Jaspersen D, Labenz J, Willich SN, et al. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis. 2006; 38 (4): 233-238.
19. Jaspersen D, Nocon M, Labenz J, et al. Clinical course of extraesophageal disorders in gastroesophageal reflux disease during routine care: a 5-year follow-up study [Abstract]. Gastroenterol. 2009; 136 (5) (suppl 1): A-739.
20. Yoshida S, Nii M, Date M. Effects of omeprazole on symptoms and quality of life in Japanese patients with reflux esophagitis: final results of OMAREE, a large-scale clinical experience investigation. BMC Gastroenterol. 2011; 11 : 15.
21. Gavazzoni FB, de Ataíde AL, Herrero Júnior FH, de Macedo Filho ED. Reflux esophagitis and reflux laryngitis: different stages of the same disease? Braz J Otorhinolaryngol. 2002; 68 (1): 86-90.
22. Pawar S, Lim HJ, Gill M, et al. Treatment of postnasal drip with proton pump inhibitors: a prospective, randomized, placebocontrolled study. Am J Rhinol. 2007; 21 (6): 695-701.
23. Allen CJ, Anvari M. Gastro-oesophageal reflux related cough and its response to laparoscopic fundoplication. Thorax. 1998; 53 (11): 963-968.
24. Allen CJ, Anvari M. Preoperative symptom evaluation and esophageal acid infusion predict response to laparoscopic Nissen fundoplication in gastroesophageal reflux patients who present with cough. Surg Endosc. 2002; 16 (7): 1037-1041.
25. Anvari M, Allen C, Goldsmith C. A randomized controlled trial of laparoscopic nissen fundoplication (LNF) versus proton pump inhibitors for treatment of patients with chronic gastro-esophageal reflux disease (GERD) who complained of cough [abstract]. Gastroenterol. 2010;138(5)(suppl 1): S-885.
26. Baldi F, Cappiello R, Cavoli C, Ghersi S, Torresan F, Roda E. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. World J Gastroenterol. 2006; 12 (1): 82-88.
27. Brouwer R, Kiroff GK. Improvement of respiratory symptoms following laparoscopic Nissen fundoplication. ANZ J Surg. 2003; 73 (4): 189-193.
28. Dore MP, Pedroni A, Pes GM, et al. Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease. Dig Dis Sci. 2007; 52 (2): 463-468.
29. Eubanks TR, Omelanczuk P, Hillel A, Maronian N, Pope CE, Pellegrini CA. Pharyngeal pH measurements in patients with respiratory symptoms before and during proton pump inhibitor therapy. Am J Surg. 2001; 181 (5): 466-470.
30. Rodríguez-Téllez M, Galera-Ruiz H, Argüelles-Arias F, Carmona I, Muñoz-Borje F, Herrerías JM. Posterior laryngitis: effects of treatment with omeprazole alone. Rev Esp Enferm Dig. 2002; 94 (3): 123-130.
31. Toros AB, Toros SZ, Ozel L, Ersoz F, Saglam M, Sametoglu F. Comparative outcomes of antireflux treatment for laryngopharyngeal reflux symptoms and upper abdominal symptoms in patients with endoscopic esophagitis. Eur Arch Oto rhinolaryngol. 2011; 268 (5): 703-708.
32. Ziora D, Jarosz W, Dzielicki J, et al. Citric acid cough threshold in patients with gastroesophageal reflux disease rises after laparoscopic fundoplication. Chest. 2005; 128 (4): 2458-2464.
33. Kopec SE, Irwin RS, French CL, Wilson MM, Bol S. A doubleblind randomized placebo-controlled trial comparing diet and/or cisapride [abstract]. Am J Respir Crit Care Med. 2001; 163 (suppl 5): A64.
34. Kiljander TO, Salomaa ER, Hietanen EK, Terho EO. Chronic cough and gastro-oesophageal reflux: a double-blind placebocontrolled study with omeprazole. Eur Respir J. 2000; 16 (4): 633-638.
35. Noordzij JP, Khidr A, Evans BA, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope. 2001; 111 (12): 2147-2151.
36. Ours TM, Kavuru MS, Schilz RJ, Richter JE. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol. 1999; 94 (11): 3131- 3138.
37. Shaheen NJ, Crockett SD, Bright SD, et al. Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011; 33 (2): 225-234.
38. Ing AJ, Ngu MC, Breslin ABX. A randomised double blind placebo controlled cross-over study of ranitidine in patients with chronic persistent cough (CPC) associated with gastrooesophageal reflux (GOR) [abstract]. Am Rev Resp Dis. 1992; 145 (4 pt 2): A11.
39. Irwin RS. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129 (suppl 1): 80S - 94S.
40. Dent J, Holloway RH, Toouli J, Dodds WJ. Mechanisms of lower oesophageal sphincter incompetence in patients with symp tomatic gastrooesophageal reflux. Gut. 1988; 29 (8): 1020- 1028.
41. Holloway RH, Dent J. Pathophysiology of gastroesophageal reflux. Lower esophageal sphincter dysfunction in gastroesophageal reflux disease. Gastroenterol Clin North Am. 1990; 19 (3): 517-535.
42. Benini L, Ferrari M, Sembenini C, et al. Cough threshold in reflux oesophagitis: influence of acid and of laryngeal and oesophageal damage. Gut. 2000; 46 (6): 762-767.
43. Mainie I, Tutuian R, Agrawal A, Adams D, Castell DO. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg. 2006; 93 (12): 1483-1487.
44. Hersh MJ, Sayuk GS, Gyawali CP. Long-term therapeutic outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough. J Clin Gastroenterol. 2010; 44 (4): 254-260.
45. Francis DO, Goutte M, Slaughter JC, et al. Traditional reflux parameters and not impedance monitoring predict outcome after fundoplication in extraesophageal reflux. Laryngoscope. 2011; 121 (9): 1902-1909.